LNC is well-poised for growth, driven by a diversified product suite, expense management efforts and solid cash reserves.
Vous n'êtes pas connecté
MET remains well-poised for growth, attributed to strength in the EMEA segment, divestiture of underperforming businesses and a commendable financial stand.
LNC is well-poised for growth, driven by a diversified product suite, expense management efforts and solid cash reserves.
Strength in the M&CS segment poises XYL well for growth. The company's measures to reward its shareholders are promising.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it...
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it...
JCI is set to benefit from strength in its Building Solutions North America segment. However, persistent weakness in system sales in China remains a...
JCI is set to benefit from strength in its Building Solutions North America segment. However, persistent weakness in system sales in China remains a...
BRO remains well-poised for growth on higher core commissions and fees, new business, solid retention, strategic acquisitions and effective capital...
POWL's strong prospects, driven by strength across its businesses, solid backlog and capacity expansionary initiatives, make it an attractive pick for...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks....
Clorox completes the divestiture of its Better Health VMS business. The company's IGNITE strategy also bodes well.